Akari Therapeutics (AKTX) Depreciation and Depletion (2014 - 2016)
Akari Therapeutics (AKTX) reported Depreciation and Depletion of $8594.0 for Q1 2016, up 1024.87% on a YoY basis from $764.0 in Q2 2015, and up 228.52% sequentially from $2616.0 in Q4 2015.
Akari Therapeutics (AKTX) Depreciation and Depletion (2014 - 2016) Analysis & Trends
Akari Therapeutics (AKTX) has 3 years of Depreciation and Depletion data on file, last reported at $8594.0 in Q1 2016.
- For the quarter ending Q1 2016, Depreciation and Depletion rose 1024.87% year-over-year to $8594.0; the trailing twelve-month figure through Mar 2016 stood at $14870.0 (up 289.78% YoY), and the FY2020 full-year result was $5013.0, down 67.47% from the prior year.
- Depreciation and Depletion improved to $8594.0 in Q1 2016, from $2616.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $8594.0 in Q1 2016 to a low of -$4576.0 in Q3 2015.
- A 3-year average of $2669.3 and a median of $1596.0 in 2014 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion plunged 414.5% in 2015 and jumped 1024.87% in 2016, its largest moves.
- Tracing AKTX's Depreciation and Depletion over 3 years: stood at $1596.0 in 2014, then jumped by 63.91% to $2616.0 in 2015, then surged by 228.52% to $8594.0 in 2016.
- Business Quant data shows AKTX's Depreciation and Depletion at $8594.0 in Q1 2016, $2616.0 in Q4 2015, and -$4576.0 in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 2.20 Mn |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 8,594.00 |
| Mar 31, 2016 | 8,594.00 |
| Dec 31, 2015 | 2,616.00 |
| Dec 31, 2015 | 2,616.00 |
| Sep 30, 2015 | -4,576.00 |
| Sep 30, 2015 | -4,576.00 |
| Jun 30, 2015 | 8,236.00 |
| Jun 30, 2015 | 8,236.00 |
| Mar 31, 2015 | 764.00 |
| Mar 31, 2015 | 764.00 |
| Dec 31, 2014 | 1,596.00 |
| Dec 31, 2014 | 1,596.00 |
| Sep 30, 2014 | 1,455.00 |
| Sep 30, 2014 | 1,455.00 |